FTC evaluates competition in biologic medicines

FTC Chairwoman Edith Ramirez kicked off a recent agency workshop by talking about the life-saving properties of biologic medicines in providing therapies for difficult to treat diseases, ranging from cancer to...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch